U.S. flag

An official website of the United States government

GTR Home > Laboratories > QDx Pathology Services, Inc.

QDx Pathology Services, Inc.

  • QDx Pathology Services, Inc., QDx Pathology Services
  • Department: Molecular
  • Edison, New Jersey, United States
  • Phone: 866-909-7284
    Fax: 908-272-1478
    Email: info@qdxpath.com
  • Website: http://www.qdxpath.com
  • Affiliated with:
    • EMES Professional Associates, Inc.

GTR Lab ID: 507679, Last updated:2021-07-16
Annual Review past due read more


  • Director: Veronica Mogerman, BA, Lab Associate Director
  • Director: Wissam Hamou, PhD, Lab Director
    Phone: (866) 909-7284 ext. 168
    Fax: (908) 272-1478
    Email: whamou@qdxpath.com
  • Director: Shazia Nishtar, MBBS, MPhil (Clinical Chemistry), Manager, Molecular Laboratory
    Phone: 866-909-7284 ext 255
    Fax: 908-272-1478
    Email: snishtar@qdxpath.com
  • M. Nasar Qureshi, PhD, MD, ABPath, FCAP, Medical Director

Conditions and tests

  • Bacterial vaginosis1 test
  • Breast-ovarian cancer, familial, susceptibility to, 13 tests
  • Breast-ovarian cancer, familial, susceptibility to, 23 tests
  • Candidiasis1 test
  • Carcinoid tumor of intestine1 test
  • Carcinoma of pancreas1 test
  • Colorectal cancer3 tests
  • Colorectal cancer, hereditary nonpolyposis, type 22 tests
  • Colorectal cancer, susceptibility to, 121 test
  • COVID-196 tests
  • Endometrial carcinoma1 test
  • Eosinophilic gastrointestinal disease2 tests
  • Familial adenomatous polyposis 11 test
  • Familial adenomatous polyposis 21 test
  • Familial cancer of breast2 tests
  • Gastrointestinal stromal tumor1 test
  • Hereditary diffuse gastric adenocarcinoma2 tests
  • Lynch syndrome 13 tests
  • Lynch syndrome 42 tests
  • Lynch syndrome 52 tests
  • Lynch syndrome 81 test
  • Malignant tumor of breast1 test
  • Malignant tumor of prostate2 tests
  • Melanoma, cutaneous malignant, susceptibility to, 12 tests
  • Melanoma, cutaneous malignant, susceptibility to, 21 test
  • Melanoma, cutaneous malignant, susceptibility to, 31 test
  • Melanoma-pancreatic cancer syndrome2 tests
  • Neoplasm of ovary1 test
  • Neoplasm of stomach2 tests
  • Pancreatic cancer, susceptibility to, 12 tests
  • Respiratory tract infectious disease1 test
  • Severe acute respiratory syndrome1 test
  • Trichomoniasis1 test
  • Tumor predisposition syndrome 31 test
  • Vaginitis1 test

List of services

  • Custom Deletion/Duplication Testing

List of certifications/licenses


  • CLIAHelp, Number: 31D2026917, Expiration date: 2023-02-03
  • CAP, Number: 9001384, Expiration date: 2022-04-05


  • CA - California Department of Public Health CDPH, Number: CDS00800656, Expiration date: 2022-01-26
  • NJ - State of New jersey Department of Health and Senior Service, Number: 0007948, Expiration date: 2021-12-31
  • NY - New York State Department of Health NYSDOH, Number: PFI9045, Expiration date: 2022-06-30
  • PA - Pennsylvania Department of Health PADOH, Number: LABID36326, Expiration date: 2022-08-15

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.